Comparing Problem Solving Treatment combined with duloxetine with Problem Solving Treatment alone for patients with major depressive disorder in primary care The primary objective is assessing the depressive symptom reduction rate of mono-treatment (PST) compared to combined treatment (PST and duloxetine) in patients with major depressive disorder. In othe...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Effectiveness of the treatment of depressive disorder and comorbid pain symptoms To establish effectiveness on severity of depression (measured by PHQ-9), of a closely monitored integrated intervention (TCCCL + duloxetine) for concomitant (sub)chronic pain and depression compared ...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Pioglitazone Influence of triglyceRide Accumulation in the Myocardium In Diabetes Not provided at time of registration

• Pays Netherlands
• Organes Aucun
• Spécialités Aucune

An Open Label Pilot Study of Atomoxetine Hydrochloride in Adolescents with Attentioin-Deficit/Hyperactivity Disorder and Comorbid Cannabis Abuse The primary objective of this study is to test the hypothesis that atomoxetine given at a dose of 1.2 mg/kg/day (once daily) for 12 weeks reduces symptoms of Attention-Deficit/Hyperactivity Disorder (...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune